The concept of immunochemosurgery in gastric cancer. - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The concept of immunochemosurgery in gastric cancer. - Suppr | 超能文献

The concept of immunochemosurgery in gastric cancer.

作者信息

Kim J P

出版信息

World J Surg. 1987 Aug;11(4):465-72. doi: 10.1007/BF01655811.

DOI:10.1007/BF01655811

Abstract

摘要

相似文献

1

The concept of immunochemosurgery in gastric cancer.

World J Surg. 1987 Aug;11(4):465-72. doi: 10.1007/BF01655811.

2

Immunochemosurgery for gastric cancer.胃癌的免疫化学外科治疗。

Semin Surg Oncol. 1985;1(3):105-15. doi: 10.1002/ssu.2980010302.

3

Immunochemosurgery as a new approach to reasonable treatment of advanced cancer.免疫化学外科作为晚期癌症合理治疗的新方法。

Ann Acad Med Singap. 1988 Jan;17(1):48-54.

4

[A study on the effectiveness of the adjuvant chemotherapy and immunotherapy and its correlation with cellular immunity].

Nihon Ika Daigaku Zasshi. 1989 Jun;56(3):308-12. doi: 10.1272/jnms1923.56.308.

5

Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.6589例胃癌患者的手术结果以及免疫化疗手术作为晚期胃癌的最佳治疗方法。

Ann Surg. 1992 Sep;216(3):269-78; discussion 278-9. doi: 10.1097/00000658-199209000-00006.

6

[Evaluation of postoperative immunochemotherapy of lung cancer].

Nihon Kyobu Geka Gakkai Zasshi. 1987 Jan;35(1):1-4.

7

[A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy].

Gan To Kagaku Ryoho. 1989 Dec;16(12):3795-9.

8

[Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].

Gan No Rinsho. 1989 Mar;35(4):512-5.

9

[A case of unresectable advanced gastric cancer with effective treatment by local administration of OK-432 on operation].

Gan To Kagaku Ryoho. 1989 Jun;16(6):2301-3.

10

[Evaluation of ACNU and 5-FU in the treatment of gliomas].

Neurol Med Chir (Tokyo). 1986 Feb;26(2):140-6. doi: 10.2176/nmc.26.140.

引用本文的文献

1

Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.多机构随机临床研究：腔内化疗单独治疗、免疫治疗单独治疗与免疫化疗治疗恶性胸腔积液的疗效比较

Br J Cancer. 1999 May;80(5-6):775-85. doi: 10.1038/sj.bjc.6690421.

2

Gastric cancer: a curable disease in Britain.胃癌：在英国可治愈的疾病。

BMJ. 1993 Sep 4;307(6904):591-6. doi: 10.1136/bmj.307.6904.591.

3

Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for gastric cancer.

本文引用的文献

1

Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.

Cancer Chemother Rep. 1972 Jun;56(3):373-85.

2

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.胃癌的两种主要组织学类型：弥漫型和所谓的肠型癌。组织学临床分类的尝试。

Acta Pathol Microbiol Scand. 1965;64:31-49. doi: 10.1111/apm.1965.64.1.31.

3

Immunological factors which influence response to immunotherapy in malignant melanoma.影响恶性黑色素瘤免疫治疗反应的免疫因素。

根据国际抗癌联盟（UICC）分期分类和日本胃癌研究学会的《胃癌研究总则》对胃癌患者术后生存曲线进行比较。

Ann Surg. 1993 Jul;218(1):47-53. doi: 10.1097/00000658-199307000-00008.

4

Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients.对3926例胃癌患者进行多因素分析的显著预后因素。

World J Surg. 1994 Nov-Dec;18(6):872-7; discussion 877-8. doi: 10.1007/BF00299091.

5

A comprehensive multi-institutional study on postoperative adjuvant immunotherapy with oral streptococcal preparation OK-432 for patients after gastric cancer surgery. Kyoto Research Group for Digestive Organ Surgery.一项关于胃癌手术后患者口服链球菌制剂OK-432进行术后辅助免疫治疗的多机构综合研究。京都消化器官外科研究小组。

Ann Surg. 1992 Jul;216(1):44-54. doi: 10.1097/00000658-199207000-00007.

Surgery. 1970 Jul;68(1):158-63; discussion 163-4.

4

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.5-氟尿嘧啶、多柔比星和丝裂霉素（FAM）联合化疗用于晚期胃癌

Ann Intern Med. 1980 Oct;93(4):533-6. doi: 10.7326/0003-4819-93-4-533.

5

Carcinoma of the stomach. Why are we falling to improve survival?胃癌。我们为何未能提高生存率？

Ann Surg. 1981 Apr;193(4):407-13. doi: 10.1097/00000658-198104000-00003.

6

A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma: The Gastrointestinal Tumor study Group.

Cancer. 1982 Apr 1;49(7):1362-6. doi: 10.1002/1097-0142(19820401)49:7<1362::aid-cncr2820490710>3.0.co;2-q.

7

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group.胃癌根治性切除术后辅助化疗的对照试验。胃肠道肿瘤研究组。

Cancer. 1982 Mar 15;49(6):1116-22. doi: 10.1002/1097-0142(19820315)49:6<1116::aid-cncr2820490609>3.0.co;2-u.

8

Gastric cancer: a controlled trial of adjuvant chemotherapy following gastrectomy.胃癌：胃切除术后辅助化疗的对照试验

Clin Oncol. 1981 Mar;7(1):13-21.

9

Postoperative long-term immunochemotherapy for esophageal carcinoma. 5 year survival.食管癌术后长期免疫化疗。5年生存率。

Jpn J Surg. 1982;12(4):249-56. doi: 10.1007/BF02469556.

10

Adjuvant chemoimmunotherapy for gastric carcinoma.胃癌的辅助化学免疫疗法。

Can J Surg. 1980 Sep;23(5):429-31.